Skip to main content

Development of acute myocardial infarction mortality and readmission models for public reporting on hospital performance in Canada

Ko DT, Ahmed T, Austin PC, Cantor WJ, Dorian P, Goldfarb M, Gong Y, Graham M, Gu J, Hawkins NM, Huynh T, Humphries KH, Koh M, Lamarche Y, Lambert L, Lawler PR, Légaré J, Ly HQ, Qiu F, Qureshi A, So D, Welsh RC, Wijeysundera HC, Wong G, Yan AT, Gurevich Y. CJC Open. 2021; 3(8):1051-9. Epub 2021 May 1. DOI:

Background — Given changes in the care and outcomes of acute myocardial infarction (AMI) patients over the past decades, we sought to develop prediction models that could be used to generate accurate risk-adjusted mortality and readmission outcomes for hospitals in current practice across Canada.

Methods — A Canadian national expert panel was convened to define appropriate AMI patients for reporting and to develop prediction models. Preliminary candidate variable evaluation was conducted using Ontario patients hospitalized with a most responsible diagnosis of AMI from April 1, 2015 to March 31, 2018. National data from the Canadian Institute for Health Information (CIHI) was used to develop AMI prediction models. The main outcomes were 30-day all-cause in-hospital mortality and 30-day urgent all-cause readmission. Discrimination of these models (measured by c-statistics) was compared with existing CIHI models in the same study cohort.

Results — AMI mortality model was assessed in 54,240 Ontario AMI patients and 153,523 AMI patients across Canada. We observed a 30-day in-hospital mortality rate of 6.3% and 30-day all-cause urgent readmission rate of 10.7% in Canada. The final Canadian AMI mortality model included 12 variables and had a c-statistic of 0.834. For readmission, the model had 13 variables and a c-statistic of 0.679. Discrimination the new AMI models had higher c-statistics compared with existing models (c-statistics 0.814 for mortality; 0.673 for readmission).

Conclusions — In this national collaboration, we developed mortality and readmission models that are suitable for profiling performance of hospitals treating AMI patients in Canada.

View full text